Screenshot of Ornithine-Transcarbamylase Deficiency Market Analysis

Ornithine-Transcarbamylase Deficiency Market Analysis

The Ornithine-Transcarbamylase deficiency market is projected to reach USD 896.6 million by 2028, growing at a CAGR of 3.4%. The deficiency causes ammonia buildup in the blood.

https://www.precisionbusinessinsights.com/market-reports/ornithine-transcarbamylase-deficiency-market/
  • Viesearch
    Moderated and indexed this listing · 4 years ago
  • ramkumar's profile picture
    @ramkumareditor
    Submitted this listing · 4 years ago

Keywords

cervic

Editorial Actions

Feature Edit